Licai He
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Redox biology and oxidative stress
- Ubiquitin and proteasome pathways
- Bioactive Natural Diterpenoids Research
- RNA modifications and cancer
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Retinoids in leukemia and cellular processes 3
- Histone Deacetylase Inhibitors Research 3
- Ubiquitin and proteasome pathways 2
- Oncology 5
- HER2/EGFR in Cancer Research 3
- Co-authors
- Haihua Gu (15 shared papers)Jiawei Cao (10 shared papers)Hongzhi Li (8 shared papers)Guang Wu (10 shared papers)Guoqiang Chen (2 shared papers)Yingli Wu (2 shared papers)Chuanxu Liu (2 shared papers)Shenmeng Gao (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Cancer Cell International (2 papers)Cell Death and Disease (2 papers)Cellular and Molecular Immunology (2 papers)Experimental Cell Research (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Licai He
21 papers receiving 560 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 105
- Molecular Biology 336
- Immunology 90
- Oncology 106
- Hematology 36
Countries citing papers authored by Licai He
This map shows the geographic impact of Licai He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Licai He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Licai He more than expected).
Fields of papers citing papers by Licai He
This network shows the impact of papers produced by Licai He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Licai He. The network helps show where Licai He may publish in the future.
Co-authors
The 25 scholars most cited alongside Licai He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 183 | |
| 2 | 2019 | 60 | |
| 3 | 2018 | 53 | |
| 4 | 2017 | 51 | |
| 5 | 2019 | 26 | |
| 6 | 2020 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2021 | 23 | |
| 9 | 2018 | 18 | |
| 10 | 2016 | 17 | |
| 11 | 2014 | 16 | |
| 12 | 2025 | 16 | |
| 13 | 2021 | 12 | |
| 14 | 2011 | 11 | |
| 15 | 2022 | 10 | |
| 16 | 2025 | 5 | |
| 17 | 2023 | 3 | |
| 18 | 2017 | 3 | |
| 19 | 2020 | 2 | |
| 20 | 2023 | 2 |
About Licai He
Licai He is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 561 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (4 papers), Retinoids in leukemia and cellular processes (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Ubiquitin and proteasome pathways (2 papers), Galectins and Cancer Biology (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (105 citations), Molecular Biology (336 citations), Immunology (90 citations), Oncology (106 citations) and Hematology (36 citations). Licai He has collaborated with scholars based in China and United States. Frequent co-authors include Haihua Gu, Jiawei Cao, Hongzhi Li, Guang Wu, Guoqiang Chen, Yingli Wu, Chuanxu Liu, Shenmeng Gao, Xin Huang and Xia Li. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cancer Cell International, Cell Death and Disease, Cellular and Molecular Immunology and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.